Today's Date
EFFicacy of Etokimab in Peanut Allergy, a Randomized Controlled Trial
(
EFFECT
)
ITN Protocol #:
ITN087AD
Branded Name:
EFFECT
Treatment Protocol #:
ITN087AD
Therapeutic Area:
Allergy & Asthma
Current Status:
Withdrawn
Summary:
Efficacy of Anti-IL33 Monoclonal Antibody Etokimab in Peanut Allergy: a Phase 2B, Double-Blind, Randomized, Placebo-controlled Trial
Clinical Operations Manager
ITN Biologist
Study Personnel:
